Regenerative Medical Technology Group Inc. Stock Analysis RMTG
Regenerative Medical Technology Group, Inc. engages in the provision of regenerative stem cell therapy. The company is headquartered in Boca Raton, Florida. The company went IPO on 2001-12-28. GSCG is a provider of regenerative medicine solutions, dedicated to advancing healthcare through patient therapies. The firm operates a portfolio of network of clinics, research facilities, and training centers. The company also distributes stem cells and other regenerative-based cell lines and equipment internationally and specializes in educating and training physicians in the area of regenerative medicine. Its services include certified training courses for physicians, manufacturing and sales of equipment and supplies, research and development of clinical protocols, regenerative medicine clinics for patients, regenerative medicine practitioners’ network, and turnkey stem cell processing center solutions. Through ISSCA, it conducts specialized training, certification, and hands-on workshops.
Read More Regenerative Medical Technology Group Inc (RMTG) Chart
Key Statistics of Regenerative Medical Technology Group Inc (RMTG)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.04Volume
500.00P/E Ratio (TTM)
-52 Week Range
Market Cap
381.03KAvg. Volume
11.83KDividend Yield
-Financial Metrics & Statements of Regenerative Medical Technology Group Inc (RMTG)
FAQ's for Regenerative Medical Technology Group Inc (RMTG)
- According to Musaffa’s Shariah screening methodology, Regenerative Medical Technology Group Inc (RMTG) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.